Rational nanoengineering and personalized strategies for overcoming cancer stem cell-driven tumor heterogeneity

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Oncology

Background:

• Tumor heterogeneity, driven by cancer stem cells (CSCs), causes therapy resistance, recurrence, and metastasis.
• Current therapies targeting CSCs face challenges in delivery efficiency and systemic toxicity.
• Nano drug delivery systems (NDDSs) present a potential solution due to their tunable properties and responsive mechanisms.

Purpose of the Study:

• To systematically review NDDS applications for targeting CSCs.
• To integrate rational carrier engineering and personalized therapeutic frameworks for CSC eradication.
• To propose a blueprint for next-generation precision nanotherapies against tumor heterogeneity.

Main Methods:

• Review of NDDS design principles for CSC targeting (surface engineering, biomimetic modification, barrier penetration).
• Evaluation of synergistic combinations of NDDS with multimodal therapies (photodynamic, sonodynamic, magnetothermal) and advanced modalities (gene editing, immunotherapy).
• Proposal of a personalized NDDS framework linking molecular subtyping with adaptive carrier engineering and feedback loops.

Main Results:

• Design principles enable efficient NDDS targeting and drug delivery to CSCs.
• Synergistic combinations enhance CSC eradication potential.
• A personalized framework offers a methodological blueprint for precision nanotherapies tailored to tumor heterogeneity.

Conclusions:

• NDDSs, through rational engineering and personalized frameworks, can overcome CSC-driven tumor heterogeneity and therapy resistance.
• Integration with multimodal and advanced therapies maximizes CSC eradication.
• Addressing clinical translation challenges is crucial for developing next-generation nanomedicine.